Leids Universitair Medisch Centrum (LUMC)
Leids Universitair Medisch Centrum (LUMC) is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A single-center, randomized, double-blind, placebo-controlled, parallel-group, proof-of-concept trial to assess the efficacy and safety of ACT-1004-1239 in adults with progressive multiple sclerosis
Sponsor Idorsia Pharmaceuticals Ltd.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A controlled, open-label post-authorisation efficacy and safety study in imlifidase desensitised kidney transplant patients with positive crossmatch against a deceased donor prior to imlifidase treatment, including non-comparative registry and concurrent reference cohorts
Sponsor Hansa Biopharma AB
- Start (EU)
- Latest update
- Estimated end
Three versus five years of adjuvant imatinib as treatment of patients with operable GIST with a high risk for recurrence: A randomised phase III study.
Sponsor Region Skane
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Leids Universitair Medisch Centrum (LUMC)?
The 2026-10-09 snapshot links Leids Universitair Medisch Centrum (LUMC) to 3 distinct CTIS trials. Recorded services include Analyze microbiology, chemistry, heamatology labs, Clinical monitoring, Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Leids Universitair Medisch Centrum (LUMC)?
The most frequently recorded therapeutic areas are Neurology. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Leids Universitair Medisch Centrum (LUMC) conducted?
The linked trials record locations in 13 countries, including Netherlands, Austria, Germany, Spain, Sweden. These are trial locations, not confirmed office locations or countries where Leids Universitair Medisch Centrum (LUMC) delivered services.
What can this page tell me about Leids Universitair Medisch Centrum (LUMC)'s trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Leids Universitair Medisch Centrum (LUMC). Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Leids Universitair Medisch Centrum (LUMC)